CHMP Issues Positive Opinion On Ipsen's Cabometyx For Advanced PNET And EpNET Patients
20/6 13:03
(RTTNews) - Ipsen (IPSEY) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Cabometyx (cabozantinib) for adult patients with unresectable or metastatic, well differentiated extra-panc...